TY  - GEN
AU  - Dai,Kun
AU  - Qin,Fengxia
AU  - Zhang,Huikun
AU  - Liu,Xiaoli
AU  - Guo,Caixia
AU  - Zhang,Ming
AU  - Gu,Feng
AU  - Fu,Li
AU  - Ma,Yongjie
TI  - Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy
SN  - 1949-2553
PY  - 2016///1103
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anthracyclines
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Bone Morphogenetic Protein Receptors, Type I
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Bridged-Ring Compounds
KW  - Carcinoma, Ductal, Breast
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Grading
KW  - Neoplasm Invasiveness
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Receptor, ErbB-2
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Taxoids
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.6613
ER  -